References

  1. Maitre T, Aubry A, Jarlier V, Robert J, Veziris N, CNR-MyRMA. Multidrug and extensively drug-resistant tuberculosis. Med Mal Infect. 2017 Feb;47(1):3-10. PubMed | Google Scholar

  2. Mazza-Stalder J, Nicod L, Janssens JP. Extrapulmonary tuberculosis. Rev Mal Respir. 2012 Apr;29(4):566-78. PubMed | Google Scholar

  3. N'guessan K, Bakayoko AS, Ahui-Brou JM, Kouakou AO, Coulibaly B, Guei A, Dosso M. Extensively drug-resistant Mycobacterium tuberculosis strains isolated in Côte d'Ivoire. Med Mal Infect. 2015 Jul;45(7):303-5. PubMed

  4. Haute Autorité de Santé. Commission de la transparence. Accessed on 20 January 2016.

  5. Das SK, Das A, Gangopadhyay A, Sinha AK. Primary disseminated extrapulmonary multidrug resistant tuberculosis. Indian J Med Microbiol. 2012 Jul-Sep; 30(3):364-6. Google Scholar

  6. Tritar F, Daghfous H, Ben Saad S, Slim-Saidi L. Management of multidrug-resistant tuberculosis. Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):130-9. PubMed

  7. Ministère de la santé du Maroc. Brochure progrès défis de la Tuberculose. 2018.

  8. Sylvie Audrey Diop, Aminata Massaly, Daye Ka, Noel Magloire Manga, Louise Fortes-Déguénonvo, Cheikh Tidiane Ndour et al. Utilisation du test GeneXpert pour le diagnostic de la tuberculose au service des maladies infectieuses du CHNU de Fann. The Pan African Medical Journal. 2016; 23:244. Google Scholar

  9. Truffot-Pernot C, Veziris N. Bacteriological tests for tuberculosis. Rev Mal Respir. 2011 Oct;28(8):1034-47. PubMed

  10. Alexander PE, De P. The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada. Can J Infect Dis Med Microbiol. 2007 Sep;18(5):289-91. PubMed | Google Scholar

  11. Fuhrman C, Veziris N, Herer B, Bonnaud F. Quelles attitudes adopter devant des séquelles de tuberculose mises en évidence sur une radiographie thoracique? Rev Mal Respir. 2004; 21: 3S65-3S73. Google Scholar

  12. Docplayer. Plan national d'accélération de la réduction de l'incidence de la tuberculose, 2013-2016. Accessed on 31 December 2013.

  13. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6. PubMed | Google Scholar

  14. Simon Tiberi, Ruaridh Buchanan, José Caminero A, Rosella Centis, Marcos Abdo Arbex, Miguel Salazar et al. The challenge of the new tuberculosis drugs. Presse Med. 2017 Mar;46(2 Pt 2):e41-e51.

  15. Fréchet-Jachym M, Métivier N. Tuberculose résistante. EMC (Elsevier Masson SAS, Paris), Pneumologie, 6-019-A-35, 2009.

  16. Prajapati K, Mishra V, Desai M, Solanki R, Naik P. Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India. Int J Mycobacteriol. 2017 Jul-Sep;6(3):289-295. Google Scholar

  17. Mittal N, Bansal P. Multidrug resistant extrapulmonary tuberculosis - three case reports and review of literature. Intern Med Inside. 2014; 2:2. Google Scholar